Repositioning: the fast track to new anti-malarial medicines? - Test2 - elhamkhani - TriplyDB

Repositioning: the fast track to new anti-malarial medicines?

Repositioning: the fast track to new anti-malarial medicines?

http://www.wikidata.org/entity/Q33612012

about

Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles Implications of the small number of distinct ligand binding pockets in proteins for drug discovery, evolution and biochemical function Predicting Mouse Liver Microsomal Stability with "Pruned" Machine Learning Models and Public Data.Plasmodium falciparum in vitro continuous culture conditions: A comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle.Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.Assessment of SYBR green I dye-based fluorescence assay for screening antimalarial activity of cationic peptides and DNA intercalating agents.Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets.Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

P2860

Q26883657-DC6D2698-E3F7-42B7-95C6-71EB69AA8F9B Q27026364-2D42B969-428D-4830-A62B-B4DFF9A0DDA7 Q30998741-D1F83ACD-8476-43A6-AB4A-60162A982DE1 Q38664678-FDB87E96-3B11-4B38-9F5B-9A1CE7EA990B Q38866063-EFB46E57-B542-4F1A-B6EF-D2B7D0F6271A Q39565472-A1706E45-DE26-49CB-86E9-8EBA93373C8B Q46322657-7A262DED-40E3-4305-A716-5F4D33CCEDFF Q47235181-EF3D00E7-C511-4DC3-8F9C-5D8824D7220F

P2860

Repositioning: the fast track to new anti-malarial medicines?

http://www.wikidata.org/entity/Q33612012

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Repositioning: the fast track to new anti-malarial medicines?

@ast

Repositioning: the fast track to new anti-malarial medicines?

@en

type

label

Repositioning: the fast track to new anti-malarial medicines?

@ast

Repositioning: the fast track to new anti-malarial medicines?

@en

prefLabel

Repositioning: the fast track to new anti-malarial medicines?

@ast

Repositioning: the fast track to new anti-malarial medicines?

@en

P1433

Q33612012-7FD07550-34E2-450C-A719-C1F3BC16F007

P1476

Q33612012-7874A447-896C-4828-9F3B-2E6ECD2E8130

P2093

Q33612012-10320A63-241E-461D-979E-72563A3E8DDF

Q33612012-3C61751C-E63B-450B-BE40-CA88516EEB7C

Q33612012-412F018E-3984-4789-843A-04BEE674AB01

Q33612012-580D98AE-3D39-4C0F-B9B8-A37B2DF0DA8B

Q33612012-A5929583-E677-4DE8-8D9D-DCF16ED34031

Q33612012-B25070DA-551A-46B5-8924-5F1CF76CD516

Q33612012-D5861AEF-FF5D-4DA8-A153-53F3E4BBECE2

Q33612012-DA112D7A-CF92-49A7-A6FB-F0ADBBBE1087

Q33612012-E1F836B0-4095-4DD6-B34C-B4733A85DA48

Q33612012-F094BF97-3BFC-41E5-A786-249A110FAE69

P2860

Q33612012-00127E7D-F87B-4509-AA34-33F1A8653388

Q33612012-006E28B8-4DC5-4C4F-B08D-DD4EF221BFE4

Q33612012-009A1933-129B-49FB-BE33-00F9B40793D0

Q33612012-015D691D-9EEF-4E6A-A82A-7072ACF3483E

Q33612012-03C91B0E-0F3C-4EC5-9DF6-259144623ED6

Q33612012-03D7A077-D5A6-4C64-8045-5A9C6561DAE4

Q33612012-0588C6D0-DBD3-4436-98B5-C4E201259A34

Q33612012-092F62CF-459C-4600-9FDD-23BC08C73F87

Q33612012-0CF015B0-67D5-48C6-8039-930297A510E7

Q33612012-141BDC3F-F1B4-47BA-83FE-860F66329B28

P2888

Q33612012-34E339E7-28D6-4EE7-B1DE-D5D863D629B7

P304

Q33612012-505D43EA-8F8E-4A06-BFF8-40D315990242

P31

Q33612012-F5F959B6-D6E2-4D2A-8335-5EEF8E446767

P356

Q33612012-6EC5E362-A68E-40AB-8B16-A1ECF1D6A48A

P478

Q33612012-0BD7F0D1-D4EB-457B-A9FA-CD92CCF2BB2A

P50

Q33612012-077755FA-0036-4D0C-805E-8D816E27646D

Q33612012-4B3C66EA-46C1-4B1C-A5AC-452F50A5F6C4

Q33612012-5C061AB5-BA01-4A58-83E1-5B7BDCB65AC9

Q33612012-7034AA9A-8A82-4432-BB18-BA8AB9399513

P577

Q33612012-D41DE3C0-6FB1-48F0-A80F-70445A86740D

P5875

Q33612012-DF6667FF-7645-4C96-928A-FC238D6575C8

P6179

Q33612012-FBE766A6-5F9E-4CCA-9848-FDF3F9E22796

P698

Q33612012-29A4C823-B0DF-4DD5-B984-74E7DA64BFA1

P921

Q33612012-5B8FC23E-1257-4509-9CE0-EFC4A72BF6D9

P932

Q33612012-7254AFE6-1C5A-4FC3-A689-B054830BB364

P356

1475-2875-13-143

P1433

Malaria Journal

P1476

Repositioning: the fast track to new anti-malarial medicines?

@en

P2093

Balachandra Bandodkar

http://www.w3.org/2001/XMLSchema#string

Francisco Javier Gamo-Benito

http://www.w3.org/2001/XMLSchema#string

Iñigo Angulo-Barturen

http://www.w3.org/2001/XMLSchema#string

Julie Clark

http://www.w3.org/2001/XMLSchema#string

Julie Lotharius

http://www.w3.org/2001/XMLSchema#string

Jörg J Möhrle

http://www.w3.org/2001/XMLSchema#string

Michele Connelly

http://www.w3.org/2001/XMLSchema#string

Nikhil Rautela

http://www.w3.org/2001/XMLSchema#string

Pavithra Viswanath

http://www.w3.org/2001/XMLSchema#string

Santiago Ferrer-Bazaga

http://www.w3.org/2001/XMLSchema#string

P2860

Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness

Thousands of chemical starting points for antimalarial lead identification

Spiroindolones, a potent compound class for the treatment of malaria

Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug

Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Global phenotypic screening for antimalarials

Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening

Human malaria parasites in continuous culture

P2888

1475-2875-13-143

P304

143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-13-143

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Timothy N C Wells

P577

2014-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261732929

http://www.w3.org/2001/XMLSchema#string

P6179

1016143285

http://www.w3.org/2001/XMLSchema#string

P698

24731288

http://www.w3.org/2001/XMLSchema#string

P921

P932

4021201

http://www.w3.org/2001/XMLSchema#string